title: Surgery for second lung cancers.
abstract: OBJECTIVE
  To evaluate the outcomes of patients surgically treated for their second primary lung cancer.
  
  
  METHODS
  In a computerized surgical registry of > 800 consecutive patients treated for primary pulmonary carcinoma since 1980, 37 patients presented with a second lung cancer. These patients were analyzed regarding their original treatment, preoperative evaluation, operative procedures, and long-term follow-up.
  
  
  RESULTS
  Three fifths of the patients were female, and 57% were > or = 65 years old at the time of their second operation. One patient originally had two synchronous tumors; another patient had three metachronous neoplasms. The interval between surgeries ranged from 5 to 239 months. In 31 patients, treatment for their original tumor was surgical resection alone. Lobectomy was the most common operation for the original tumor, and 78% were stage I. When the second tumor was diagnosed, 25 patients (68%) were asymptomatic. Eight patients (22%) were current smokers, and 29 patients (78%) were former smokers. The most common operation for the second tumor was a lobectomy. Surgical mortality was 5.4%. Nineteen patients (51%) survived 2 years, and 9 patients (24%) survived > or = 5 years. Eleven patients (30%) were still alive at last follow-up, 3 to 198 months postoperatively, and only 13 patients (34%) had died of their cancer.
  
  
  CONCLUSIONS
  Surgical treatment of second primary pulmonary neoplasms can be performed in selected patients with acceptable long-term survival.
authors: Oregon Clinic, PC, Providence Portland Medical Center, Portland, OR 97213, USA.
authors: J W
authors: JW
authors: Asaph
authors: J F
authors: JF
authors: Keppel
authors: J R
authors: JR
authors: Handy
authors: E C
authors: EC
authors: Douville
authors: A C
authors: AC
authors: Tsen
authors: G Y
authors: GY
authors: Ott
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D008297:Male; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*